Emergent BioSolutions, Inc. (EBS)
6.75
+0.39
(+6.13%)
USD |
NYSE |
Sep 16, 16:00
6.75
0.00 (0.00%)
Pre-Market: 07:54
Emergent BioSolutions Total Return Level : 6.75 for Sept. 16, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 16, 2026 | 6.75 |
| September 15, 2026 | 6.36 |
| September 14, 2026 | 6.38 |
| September 11, 2026 | 6.23 |
| September 10, 2026 | 5.87 |
| September 09, 2026 | 5.68 |
| September 08, 2026 | 6.00 |
| September 04, 2026 | 6.21 |
| September 03, 2026 | 6.23 |
| September 02, 2026 | 6.46 |
| September 01, 2026 | 6.22 |
| August 31, 2026 | 6.10 |
| August 28, 2026 | 5.91 |
| August 27, 2026 | 5.94 |
| August 26, 2026 | 5.97 |
| August 25, 2026 | 5.64 |
| August 24, 2026 | 5.18 |
| August 21, 2026 | 5.08 |
| August 20, 2026 | 4.82 |
| August 19, 2026 | 4.89 |
| August 18, 2026 | 4.66 |
| August 17, 2026 | 4.50 |
| August 14, 2026 | 4.59 |
| August 13, 2026 | 4.49 |
| August 12, 2026 | 4.55 |
| Date | Value |
|---|---|
| August 11, 2026 | 4.45 |
| August 10, 2026 | 4.47 |
| August 07, 2026 | 4.84 |
| August 06, 2026 | 5.31 |
| August 05, 2026 | 7.54 |
| August 04, 2026 | 7.57 |
| August 03, 2026 | 7.41 |
| July 31, 2026 | 7.22 |
| July 30, 2026 | 7.26 |
| July 29, 2026 | 7.35 |
| July 28, 2026 | 7.31 |
| July 27, 2026 | 7.33 |
| July 24, 2026 | 7.26 |
| July 23, 2026 | 7.50 |
| July 22, 2026 | 7.58 |
| July 21, 2026 | 7.65 |
| July 20, 2026 | 7.69 |
| July 17, 2026 | 7.63 |
| July 16, 2026 | 7.69 |
| July 15, 2026 | 7.89 |
| July 14, 2026 | 7.50 |
| July 13, 2026 | 8.01 |
| July 10, 2026 | 8.05 |
| July 09, 2026 | 8.18 |
| July 08, 2026 | 8.14 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Exelixis, Inc. | 56.78 |
| Capricor Therapeutics, Inc. | 8.56 |
| ADMA Biologics, Inc. | 8.90 |
| Akebia Therapeutics, Inc. | 0.9178 |
| Arcutis Biotherapeutics, Inc. | 26.14 |